Home › Neuroblastoma › Minnesota
Neuroblastoma clinical trials in Minnesota
9 studies for Neuroblastoma are looking for participants at sites in Minnesota.
Cities in Minnesota
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
- Children's Hospitals and Clinics of Minnesota - Minneapolis, Minneapolis
- University of Minnesota/Masonic Cancer Center, Minneapolis
- Mayo Clinic in Rochester, Rochester
RecruitingPhase 3
Up to age 30 · All sexes · Updated Sep 24, 2026 · NCT06172296Biomarkers of Resiliency In Childhood Cancer Surgery
- Mayo Clinic, Rochester
RecruitingObservational study
Ages 3 to 25 · All sexes · Updated Sep 14, 2026 · NCT06674811Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
- Children's Hospital and Clinics of Minnesota, Minneapolis
RecruitingPhase 2
Up to age 22 · All sexes · Updated Sep 4, 2026 · NCT02559778Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- University of Minnesota/Masonic Cancer Center, Minneapolis
RecruitingPhase 1/2
12 Months – 30 Years · All sexes · Updated Aug 25, 2026 · NCT04851119Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
- Children's Hospitals and Clinics of Minnesota - Minneapolis, Minneapolis
- University of Minnesota/Masonic Cancer Center, Minneapolis
- Mayo Clinic in Rochester, Rochester
RecruitingPhase 3
365 Days – 30 Years · All sexes · Updated Aug 25, 2026 · NCT03126916Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
- Children's Hospital and Clinics of Minnesota, Minneapolis
RecruitingPhase 2
12 Months – 21 Years · All sexes · Updated Aug 12, 2026 · NCT05489887Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
- Children's Hospital and Clinics of Minn, Minneapolis
RecruitingPhase 1/2
12 Months – 30 Years · All sexes · Updated May 19, 2026 · NCT04901702Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- Masonic Cancer Center, University of Minnesota, Minneapolis
RecruitingPhase 2
Up to age 30 · All sexes · Updated Oct 21, 2025 · NCT02605421International PPB/DICER1 Registry
- Children's Minnesota, Minneapolis
RecruitingObservational studyHealthy volunteers welcome
0 Minutes – 100 Years · All sexes · Updated Jan 30, 2025 · NCT03382158From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.